| Molecular basis of alpha-thalassemia |
21 |
| Silencing of circ_0009910 inhibits acute myeloid leukemia cell growth through increasing miR-20a-5p |
19 |
| Molecular basis of beta thalassemia and potential therapeutic targets |
18 |
| Structure and function of haemoglobins |
17 |
| CircBA9.3 supports the survival of leukaemic cells by up-regulating c-ABL1 or BCR-ABL1 protein levels |
15 |
| Mechanisms of anti-cancer effects of ascorbate: Cytotoxic activity and epigenetic modulation |
11 |
| Rutin and curcumin reduce inflammation, triglyceride levels and ADA activity in serum and immune cells in a model of hyperlipidemia |
9 |
| Management goals for type 1 Gaucher disease: An expert consensus document from the European working group on Gaucher disease |
8 |
| Validating glycoprotein non-metastatic melanoma B (gpNMB, osteoactivin), a new biomarker of Gaucher disease |
8 |
| Acute neonatal bilirubin encephalopathy in the State of Utah 2009-2018 |
7 |
| Energy balance, glucose and lipid metabolism, cardiovascular risk and liver disease burden in adult patients with type 1 Gaucher disease |
7 |
| Are transient and shear wave elastography useful tools in Gaucher disease? |
7 |
| A pooled analysis of adverse events in 393 adults with Gaucher disease type 1 from four clinical trials of oral eliglustat: Evaluation of frequency, timing, and duration |
7 |
| Causes of death in 184 patients with type 1 Gaucher disease from the United States who were never treated with enzyme replacement therapy |
7 |
| HemoTypeSC, a low-cost point-of-care testing device for sickle cell disease: Promises and challenges |
7 |
| Gene therapy and gene editing strategies for hemoglobinopathies |
7 |
| Ferritin iron regulators, PCBP1 and NCOA respond to cellular iron status in developing red cells |
6 |
| The additive effect on the antiepileptic treatment of ambroxol in type 3 Gaucher patient. The early observation |
6 |
| Liver involvement in Gaucher disease - Review and clinical approach |
5 |
| In-depth phenotypic characterization of reticulocyte maturation using mass cytometry |
5 |
| F8 inversions of introns 22 and 1 confer a moderate risk of inhibitors in Mexican patients with severe hemophilia A. Concordance analysis and literature review |
5 |
| Priapism, hemoglobin desaturation, and red blood cell adhesion in men with sickle cell anemia |
5 |
| No increased cerebrovascular involvement in adult beta-thalassemia by advanced MRI analyses |
5 |
| Scurvy, an old story in a new time: The hematologist's experience |
5 |
| Oxidative pathways in the sickle cell and beyond |
5 |
| Borderline hemoglobin A(2) levels in northern Thai population: HBB genotypes and effects of coinherited alpha-thalassemia |
4 |
| Plasma-based protein biomarkers can predict the risk of acute graft-versus-host disease and non-relapse mortality in patients undergoing allogeneic hematopoietic stem cell transplantation |
4 |
| Circulating microvesicles are less procoagulant and carry different miRNA cargo in myelodysplasia |
4 |
| Losartan therapy decreases albuminuria with stable glomerular filtration and permselectivity in sickle cell anemia |
4 |
| Impact of chromosome alterations, genetic mutations and clonal hematopoiesis of indeterminate potential (CHIP) on the classification and risk stratification of MDS |
4 |
| UPR activation and CHOP mediated induction of GBA1 transcription in Gaucher disease |
4 |
| Ferritinemia and serum inflammatory cytokines in Swedish adults with Gaucher disease type 1 |
4 |
| Factors affecting thrombohemorrhagic early death in patients with acute promyelocytic leukemia treated with arsenic trioxide alone |
4 |
| Comprehensive analysis the potential biomarkers for the high-risk of childhood acute myeloid leukemia based on a competing endogenous RNA network |
4 |
| Design of a framework for the deployment of collaborative independent rare disease-centric registries: Gaucher disease registry model |
4 |
| Recent trends in treatment of thalassemia |
4 |
| Ferritin in serum and urine: A pilot study |
4 |
| Variability of homozygous sickle cell disease: The role of alpha and beta globin chain variation and other factors |
4 |
| Evolution of hemoglobin loci and their regulatory elements |
4 |
| Natural history of benign ethnic neutropenia in individuals of African ancestry |
4 |
| Favourable improvement in haematological parameters in response to oral iron and vitamin C combination in children with Iron Refractory Iron Deficiency Anemia (IRIDA) phenotype |
4 |
| An efficient method to generate xenograft tumor models of acute myeloid leukemia and hepatocellular carcinoma in adult zebrafish |
4 |
| Gaucheromas: When macrophages promote tumor formation and dissemination |
4 |
| Assessment of the liver and spleen in children with Gaucher disease type I with diffusion-weighted MR imaging |
3 |
| The role of high density lipoprotein in Type 1 Gaucher disease |
3 |
| Biomarker signatures of sickle cell disease severity |
3 |
| Identification of promising prognostic genes for relapsed acute lymphoblastic leukemia |
3 |
| Screening umbilical cord blood for congenital Iron deficiency |
3 |
| Evidence for three populations of the glucose transporter in the human erythrocyte membrane |
3 |
| Adult onset hereditary hemochromatosis is associated with a novel recurrent Hemojuvelin (HJV) gene mutation in north Indians |
3 |
